Private company

CASI Pharmaceuticals, Inc (DE)

Last updated Oct 16, 2026.

Overview

$38.0MRevenue, fiscal 20222
-$41.0MNet income, fiscal 20222
  • IndustryBiological Products, (No Diagnostic Substances)
  • HeadquartersDE
  • Incorporated inDE3
  • Business address9620 Medical Center Dr, Ste 300, Rockville, Md 208503
  • Filer categoryNon-accelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-89.4%Operating margin2
-107.8%Net margin2
26.7%Revenue growth, 20222
-92.0%Return on equity2
-$26.7MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue42¢$15.8M
  • Other costs53¢$20.2M
  • Income tax5¢$2.0M

Out of $38.0M in revenue.2 The company lost money this year.

Financial statements

Revenue456782$38.0M in 2022+79643% since 2015
0$10.0M$20.0M$30.0M$40.0M2015: $47.7K$47.7K20152016: $0$020162017: $0$020172018: $0$020182019: $4.1M$4.1M20192020: $15.0M$15.0M2020+269%2021: $30.0M$30.0M2021+100%2022: $38.0M$38.0M2022+27%
Gross profit9$17.6M in 2021+213% since 2020
0$5.0M$10.0M$15.0M$20.0M2020: $5.6M$5.6M20202021: $17.6M$17.6M2021+213%
Operating income782-$34.0M in 2022+25% since 2018
-$60.0M-$40.0M-$20.0M02018: -$27.2M-$27.2M20182019: -$47.0M-$47.0M2019+73%2020: -$52.8M-$52.8M2020+12%2021: -$41.5M-$41.5M2021−21%2022: -$34.0M-$34.0M2022−18%
Net income456782-$41.0M in 2022+469% since 2015
-$60.0M-$40.0M-$20.0M02015: -$7.2M-$7.2M20152016: -$9.5M-$9.5M2016+31%2017: -$10.8M-$10.8M2017+14%2018: -$27.5M-$27.5M2018+155%2019: -$46.0M-$46.0M2019+68%2020: -$48.3M-$48.3M2020+5%2021: -$36.7M-$36.7M2021−24%2022: -$41.0M-$41.0M2022+12%
Fiscal year20152016201720182019202020212022
Revenue$47.7K4$05$06$07$4.1M8$15.0M2$30.0M2$38.0M2
Cost of revenue$6.3K4$04$07$3.9M8$9.5M2$12.6M2$15.8M2
Gross profit$5.6M9$17.6M9
Research and development$4.1M4$4.6M5$7.6M6$8.5M7$9.7M7
Operating income-$27.2M7-$47.0M8-$52.8M2-$41.5M2-$34.0M2
Interest$7.5K6$7.5K7$5.6K7$3.1K2$2.9K2$02
Income tax$04$05$06$07$08$02$02$2.0M2
Net income-$7.2M4-$9.5M5-$10.8M6-$27.5M7-$46.0M8-$48.3M2-$36.7M2-$41.0M2
Earnings per share-$0.449-$0.279
Earnings per share (diluted)-$0.449-$0.279

Compare CASI Pharmaceuticals, Inc (DE) with another company

Former names

  • CASI Pharmaceuticals, Inc.Aug 14, 2014 to Feb 21, 20233
  • ENTREMED INCMay 14, 1996 to Jun 13, 20143

Recent filings

  1. Mar 21, 20238-K
  2. Feb 14, 2023DEF 14A
  3. Jan 31, 20238-K
  4. Nov 14, 202210-Q
  5. Nov 14, 20228-K
  6. Sep 23, 20228-K
  7. Sep 9, 20224 OWNERSHIP DOCUMENT
  8. Sep 8, 20224 FORM 4 SUBMISSION
  9. Sep 2, 20224 FORM 4 SUBMISSION
  10. Aug 26, 20224 FORM 4 SUBMISSION
  11. Aug 23, 20224 FORM 4 SUBMISSION
  12. Aug 12, 202210-Q
  13. Aug 12, 20228-K
  14. Jun 17, 20224 OWNERSHIP DOCUMENT
  15. May 26, 20224 OWNERSHIP DOCUMENT

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11